TESTOSTERONE

TESTOSTERONE was reported 23692 times

TESTOSTERONE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PERFORMANCE ENHANCING PRODUCT USE 27 0.2727
1 SEXUAL RELATIONSHIP CHANGE 18 0.2169
2 VIRILISM 23 0.2091
3 POLYCYTHAEMIA 297 0.1438
4 CERVIX CARCINOMA STAGE IV 20 0.1379
5 TOXIC CARDIOMYOPATHY 29 0.1295
6 SECONDARY HYPOGONADISM 42 0.1273
7 BLOOD TESTOSTERONE INCREASED 238 0.1106
8 EXPULSION OF MEDICATION 57 0.1078
9 ACNE FULMINANS 20 0.1020
10 ENLARGED CLITORIS 16 0.0970
11 BLOOD LUTEINISING HORMONE DECREASED 17 0.0950
12 PRODUCT DEPOSIT 147 0.0943
13 PRECOCIOUS PUBERTY 50 0.0876
14 BLOOD FOLLICLE STIMULATING HORMONE DECREASED 15 0.0852
15 HEPATIC ADENOMA 42 0.0812
16 RENAL ARTERY THROMBOSIS 23 0.0744
17 CLEAR CELL RENAL CELL CARCINOMA 50 0.0718
18 BREAST HYPERPLASIA 25 0.0710
19 PILONIDAL DISEASE 17 0.0708
20 CENTRAL SEROUS CHORIORETINOPATHY 47 0.0688
21 OESTRADIOL INCREASED 20 0.0664
22 BLOOD TESTOSTERONE DECREASED 446 0.0651
23 BREATHING-RELATED SLEEP DISORDER 15 0.0633
24 CRANIOPHARYNGIOMA 21 0.0633
25 IDIOPATHIC INTRACRANIAL HYPERTENSION 119 0.0529
26 BLOOD GROWTH HORMONE INCREASED 28 0.0502
27 TESTICULAR ATROPHY 43 0.0493
28 METAPLASIA 23 0.0487
29 MUSCLE MASS 22 0.0487
30 BLOOD TESTOSTERONE ABNORMAL 53 0.0479
31 MESENTERIC VEIN THROMBOSIS 45 0.0451
32 ENDOMETRIAL ADENOCARCINOMA 28 0.0440
33 BLOOD OESTROGEN INCREASED 24 0.0407
34 BLOOD OESTROGEN DECREASED 28 0.0398
35 INFERTILITY MALE 18 0.0398
36 RENAL INFARCT 56 0.0387
37 HYPOGONADISM 39 0.0386
38 POLYCYTHAEMIA VERA 27 0.0330
39 PALMOPLANTAR PUSTULOSIS 17 0.0321
40 CARDIAC VENTRICULAR THROMBOSIS 38 0.0294
41 INSULIN-LIKE GROWTH FACTOR INCREASED 42 0.0294
42 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 47 0.0293
43 CORONARY ARTERY DISSECTION 25 0.0291
44 PRODUCT DELIVERY MECHANISM ISSUE 154 0.0286
45 ISCHAEMIA 130 0.0283
46 HAEMATOCRIT INCREASED 64 0.0281
47 MYOCARDIAL FIBROSIS 23 0.0274
48 OBSTRUCTIVE SLEEP APNOEA SYNDROME 39 0.0267
49 PHAEOCHROMOCYTOMA 16 0.0243
50 BRUGADA SYNDROME 25 0.0242
51 CARDIAC DEATH 27 0.0224
52 UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE 24 0.0218
53 IMPLANT SITE BRUISING 16 0.0214
54 CEREBRAL VENOUS SINUS THROMBOSIS 18 0.0213
55 INFARCTION 137 0.0200
56 RECALLED PRODUCT 34 0.0196
57 PITUITARY TUMOUR BENIGN 32 0.0196
58 IMPLANT SITE SWELLING 19 0.0186
59 IMPLANT SITE INFECTION 43 0.0185
60 ECONOMIC PROBLEM 276 0.0182
61 PARTNER STRESS 17 0.0177
62 PRODUCT PHYSICAL CONSISTENCY ISSUE 98 0.0177
63 BONE DEMINERALISATION 18 0.0170
64 LYMPHOPROLIFERATIVE DISORDER 48 0.0163
65 LEFT VENTRICULAR HYPERTROPHY 69 0.0161
66 RED BLOOD CELL COUNT INCREASED 42 0.0152
67 HAEMOGLOBIN INCREASED 68 0.0149
68 PORTAL VEIN THROMBOSIS 48 0.0148
69 DILATED CARDIOMYOPATHY 15 0.0148
70 IMPLANT SITE PAIN 66 0.0148
71 QUALITY OF LIFE DECREASED 193 0.0144
72 ACUTE MYOCARDIAL INFARCTION 417 0.0141
73 INVASIVE DUCTAL BREAST CARCINOMA 38 0.0140
74 DEEP VEIN THROMBOSIS 880 0.0135
75 ISCHAEMIC CARDIOMYOPATHY 40 0.0130
76 AORTIC THROMBOSIS 15 0.0130
77 LIBIDO INCREASED 26 0.0128
78 PRODUCT ODOUR ABNORMAL 132 0.0126
79 SELF-MEDICATION 51 0.0124
80 ENDOMETRIAL CANCER 27 0.0123
81 PAPILLOEDEMA 53 0.0117
82 HYPERCOAGULATION 22 0.0115
83 CORONARY ARTERY THROMBOSIS 23 0.0114
84 PHYSICAL DISABILITY 50 0.0113
85 THROMBOPHLEBITIS SUPERFICIAL 34 0.0112
86 LIQUID PRODUCT PHYSICAL ISSUE 81 0.0111
87 CEREBRAL VENOUS THROMBOSIS 20 0.0110
88 CORONARY ARTERY DISEASE 323 0.0107
89 CEREBROSPINAL FLUID LEAKAGE 19 0.0103
90 ADRENOCORTICAL INSUFFICIENCY ACUTE 20 0.0102
91 PULMONARY INFARCTION 24 0.0101
92 VENTRICULAR HYPERTROPHY 25 0.0100
93 CARDIOVASCULAR DISORDER 251 0.0099
94 PRE-EXISTING CONDITION IMPROVED 61 0.0098
95 PRESCRIBED OVERDOSE 189 0.0098
96 CARDIOMYOPATHY 142 0.0096
97 ANHEDONIA 252 0.0096
98 HAIR GROWTH ABNORMAL 64 0.0092
99 LACUNAR INFARCTION 22 0.0092
100 PULMONARY EMBOLISM 848 0.0089
101 ACCIDENTAL EXPOSURE 37 0.0089
102 HEART INJURY 22 0.0088
103 SLEEP APNOEA SYNDROME 167 0.0087
104 THROMBOCYTOSIS 32 0.0087
105 HYPERTRICHOSIS 16 0.0086
106 PROSTATOMEGALY 33 0.0084
107 LOSS OF EMPLOYMENT 25 0.0083
108 HORMONE LEVEL ABNORMAL 39 0.0080
109 EMBOLISM VENOUS 24 0.0079
110 PRODUCT CONTAMINATION PHYSICAL 20 0.0079
111 MULTIPLE USE OF SINGLE-USE PRODUCT 44 0.0078
112 PRIAPISM 27 0.0078
113 OPTIC ISCHAEMIC NEUROPATHY 30 0.0077
114 ERECTILE DYSFUNCTION 192 0.0075
115 SUDDEN CARDIAC DEATH 25 0.0073
116 SOCIAL PROBLEM 30 0.0072
117 HIGH DENSITY LIPOPROTEIN DECREASED 24 0.0072
118 CHOLESTATIC LIVER INJURY 16 0.0072
119 BENIGN PROSTATIC HYPERPLASIA 37 0.0072
120 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 16 0.0071
121 POOR QUALITY PRODUCT ADMINISTERED 74 0.0070
122 LOSS OF LIBIDO 63 0.0070
123 INTRACRANIAL PRESSURE INCREASED 39 0.0070
124 CONGESTIVE CARDIOMYOPATHY 29 0.0070
125 ARTERIOSCLEROSIS CORONARY ARTERY 46 0.0069
126 TESTICULAR PAIN 22 0.0069
127 INTRACARDIAC THROMBUS 21 0.0068
128 OSTEOPENIA 103 0.0068
129 FAMILY STRESS 21 0.0068
130 URINARY HESITATION 16 0.0067
131 ANORGASMIA 18 0.0066
132 PLANTAR FASCIITIS 22 0.0066
133 NEOPLASM RECURRENCE 22 0.0065
134 PERIPHERAL ISCHAEMIA 26 0.0064
135 RETINAL VEIN OCCLUSION 18 0.0063
136 IMPAIRED WORK ABILITY 133 0.0062
137 RENAL CELL CARCINOMA 30 0.0061
138 VENOUS THROMBOSIS 24 0.0061
139 SNORING 23 0.0061
140 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 37 0.0060
141 BLOOD THYROID STIMULATING HORMONE DECREASED 27 0.0059
142 ACUTE CORONARY SYNDROME 49 0.0059
143 MYOCARDIAL INFARCTION 1021 0.0058
144 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 39 0.0057
145 CAROTID ARTERY STENOSIS 20 0.0057
146 PRODUCT CONTAINER ISSUE 49 0.0057
147 LEFT VENTRICULAR DYSFUNCTION 38 0.0057
148 AORTIC ANEURYSM 43 0.0056
149 PRODUCT ADMINISTRATION INTERRUPTED 44 0.0056
150 DIASTOLIC DYSFUNCTION 17 0.0055
151 LUMBAR SPINAL STENOSIS 16 0.0055
152 AORTIC STENOSIS 19 0.0055
153 BUNDLE BRANCH BLOCK RIGHT 25 0.0054
154 LACERATION 50 0.0053
155 NEPHROPATHY 49 0.0052
156 WOUND COMPLICATION 18 0.0052
157 PERIPHERAL VASCULAR DISORDER 27 0.0052
158 THROMBOSIS 421 0.0052
159 LEFT VENTRICULAR FAILURE 18 0.0052
160 DRUG ADMINISTERED AT INAPPROPRIATE SITE 55 0.0052
161 OSTEONECROSIS 170 0.0052
162 MUSCLE RUPTURE 20 0.0051
163 HEPATOCELLULAR CARCINOMA 39 0.0051
164 ATRIAL FLUTTER 40 0.0050
165 PRODUCT RESIDUE PRESENT 27 0.0050
166 VENTRICULAR HYPOKINESIA 16 0.0050
167 DRUG ABUSE 413 0.0050
168 AORTIC VALVE INCOMPETENCE 21 0.0049
169 CEREBROVASCULAR ACCIDENT 834 0.0049
170 PROSTATIC SPECIFIC ANTIGEN INCREASED 66 0.0048
171 ARTERIOSCLEROSIS 45 0.0048
172 APPLICATION SITE RASH 65 0.0047
173 POOR QUALITY DRUG ADMINISTERED 30 0.0046
174 FEAR 123 0.0046
175 TENDON INJURY 17 0.0046
176 NEPHROGENIC ANAEMIA 21 0.0045
177 PROSTATIC DISORDER 25 0.0045
178 DYSLIPIDAEMIA 23 0.0045
179 RECALLED PRODUCT ADMINISTERED 43 0.0045
180 MUSCLE FATIGUE 19 0.0045
181 VISUAL FIELD DEFECT 32 0.0044
182 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 81 0.0044
183 TRANSIENT ISCHAEMIC ATTACK 149 0.0044
184 CORONARY ARTERY OCCLUSION 60 0.0044
185 NOCTURIA 53 0.0044
186 HYPERLIPIDAEMIA 52 0.0043
187 PRODUCT PHYSICAL ISSUE 87 0.0043
188 MULTIPLE INJURIES 27 0.0043
189 CARDIAC FAILURE CONGESTIVE 343 0.0043
190 APPLICATION SITE IRRITATION 53 0.0043
191 EMBOLISM 35 0.0042
192 SPINAL OSTEOARTHRITIS 37 0.0042
193 FOOD CRAVING 22 0.0042
194 EMOTIONAL DISORDER 126 0.0041
195 ENERGY INCREASED 24 0.0041
196 CARDIAC FAILURE ACUTE 27 0.0040
197 SKIN PAPILLOMA 16 0.0040
198 AUTOIMMUNE THYROIDITIS 15 0.0040
199 SKIN LACERATION 43 0.0040
200 MITRAL VALVE INCOMPETENCE 44 0.0039
201 APPLICATION SITE EXFOLIATION 16 0.0039
202 PRODUCT ADMINISTRATION ERROR 78 0.0039
203 ERECTION INCREASED 16 0.0038
204 NERVE INJURY 42 0.0038
205 HOMICIDAL IDEATION 15 0.0037
206 VENTRICULAR FIBRILLATION 41 0.0037
207 BRAIN INJURY 37 0.0037
208 AFFECTIVE DISORDER 29 0.0037
209 APPLICATION SITE PAIN 81 0.0037
210 MYOCARDITIS 42 0.0037
211 TONGUE DISCOLOURATION 16 0.0037
212 PSYCHIATRIC SYMPTOM 27 0.0037
213 FEELING OF DESPAIR 17 0.0036
214 AORTIC DISSECTION 15 0.0036
215 ISCHAEMIC STROKE 64 0.0036
216 BRAIN FOG 56 0.0036
217 PRODUCT SOLUBILITY ABNORMAL 18 0.0036
218 ANGINA UNSTABLE 23 0.0035
219 ATELECTASIS 34 0.0035
220 PRODUCT COLOUR ISSUE 18 0.0035
221 SOMNAMBULISM 23 0.0035
222 HORDEOLUM 15 0.0035
223 BLOOD CHOLESTEROL ABNORMAL 16 0.0035
224 DYSPHEMIA 15 0.0034
225 FLANK PAIN 32 0.0034
226 BLOOD TRIGLYCERIDES INCREASED 60 0.0034
227 SCOLIOSIS 21 0.0034
228 CORONARY ARTERY STENOSIS 17 0.0034
229 ANXIETY 961 0.0034
230 MALIGNANT MELANOMA 45 0.0034
231 LOW DENSITY LIPOPROTEIN INCREASED 26 0.0034
232 INTERVERTEBRAL DISC DEGENERATION 31 0.0033
233 GLOMERULAR FILTRATION RATE DECREASED 41 0.0033
234 POST-TRAUMATIC STRESS DISORDER 22 0.0033
235 ROTATOR CUFF SYNDROME 42 0.0033
236 MYOCARDIAL ISCHAEMIA 37 0.0032
237 SEXUAL DYSFUNCTION 38 0.0032
238 DIVERTICULUM 23 0.0032
239 CONCUSSION 25 0.0032
240 EYE MOVEMENT DISORDER 22 0.0032
241 PRODUCT LEAKAGE 18 0.0032
242 CARDIOGENIC SHOCK 46 0.0032
243 HICCUPS 26 0.0032
244 DRUG TOLERANCE 16 0.0032
245 MUSCLE ATROPHY 40 0.0032
246 BRAIN NEOPLASM 29 0.0032
247 ATRIAL FIBRILLATION 303 0.0031
248 VITAMIN D DEFICIENCY 30 0.0031
249 RENAL TUBULAR NECROSIS 30 0.0031
250 ARTERIAL OCCLUSIVE DISEASE 24 0.0031
251 DIABETIC NEUROPATHY 15 0.0030
252 NASAL DISCOMFORT 24 0.0030
253 SPINAL COMPRESSION FRACTURE 25 0.0030
254 MUSCLE STRAIN 26 0.0030
255 POLLAKIURIA 125 0.0030
256 COMPRESSION FRACTURE 16 0.0030
257 SQUAMOUS CELL CARCINOMA OF SKIN 18 0.0030
258 STRESS FRACTURE 16 0.0030
259 END STAGE RENAL DISEASE 54 0.0030
260 CORONARY ARTERIAL STENT INSERTION 15 0.0030
261 ANGER 100 0.0030
262 EXOSTOSIS 27 0.0030
263 OSTEOPOROSIS 121 0.0029
264 APPLICATION SITE VESICLES 19 0.0029
265 MENISCUS INJURY 18 0.0029
266 CARDIOMEGALY 36 0.0029
267 TENDON RUPTURE 36 0.0029
268 UPPER-AIRWAY COUGH SYNDROME 24 0.0029
269 APPLICATION SITE PRURITUS 66 0.0029
270 BONE DENSITY DECREASED 91 0.0029
271 CHRONIC KIDNEY DISEASE 220 0.0029
272 LARGE INTESTINE POLYP 20 0.0029
273 INTERVERTEBRAL DISC PROTRUSION 63 0.0029
274 PRODUCT FORMULATION ISSUE 19 0.0029
275 MAJOR DEPRESSION 21 0.0029
276 SKIN INFECTION 32 0.0028
277 POLYURIA 23 0.0028
278 AFFECT LABILITY 27 0.0028
279 DECREASED ACTIVITY 30 0.0028
280 EMOTIONAL DISTRESS 334 0.0028
281 BACK INJURY 30 0.0028
282 HEPATOMEGALY 27 0.0027
283 HEART RATE IRREGULAR 62 0.0027
284 OBSESSIVE-COMPULSIVE DISORDER 22 0.0027
285 PROCEDURAL COMPLICATION 21 0.0027
286 FRUSTRATION TOLERANCE DECREASED 22 0.0027
287 DECREASED INTEREST 16 0.0027
288 BLINDNESS TRANSIENT 20 0.0027
289 SKIN MASS 18 0.0027
290 POOR QUALITY SLEEP 58 0.0027
291 BASAL CELL CARCINOMA 42 0.0027
292 GOUT 48 0.0027
293 PROTHROMBIN TIME PROLONGED 16 0.0027
294 APPLICATION SITE ERYTHEMA 70 0.0027
295 NIGHT SWEATS 86 0.0027
296 BREAST TENDERNESS 20 0.0027
297 PRODUCT LABEL ISSUE 18 0.0027
298 IMPAIRED GASTRIC EMPTYING 36 0.0026
299 GINGIVAL PAIN 21 0.0026
300 ADRENAL INSUFFICIENCY 32 0.0026
301 BONE DISORDER 48 0.0026
302 DERMATITIS CONTACT 30 0.0026
303 MIDDLE INSOMNIA 49 0.0026
304 HYPERPROLACTINAEMIA 17 0.0026
305 INTENTIONAL PRODUCT MISUSE 227 0.0026
306 CONCOMITANT DISEASE AGGRAVATED 16 0.0026
307 CYST 32 0.0026
308 INJURY 181 0.0026
309 VITAMIN D DECREASED 22 0.0026
310 OBESITY 41 0.0026
311 PRODUCT SUBSTITUTION ISSUE 148 0.0026
312 DRUG EFFECT LESS THAN EXPECTED 38 0.0026
313 THERAPEUTIC RESPONSE UNEXPECTED 115 0.0026
314 SPLENOMEGALY 30 0.0026
315 APPLICATION SITE REACTION 18 0.0026
316 OSTEOARTHRITIS 108 0.0025
317 SEASONAL ALLERGY 36 0.0025
318 MOOD SWINGS 81 0.0025
319 CEREBRAL INFARCTION 62 0.0025
320 PRODUCT PACKAGING ISSUE 24 0.0025
321 PRODUCT ADHESION ISSUE 90 0.0025
322 TRICUSPID VALVE INCOMPETENCE 20 0.0025
323 PANIC ATTACK 91 0.0025
324 DISTURBANCE IN ATTENTION 134 0.0025
325 PULMONARY MASS 37 0.0025
326 BIPOLAR DISORDER 27 0.0025
327 PERSONALITY CHANGE 23 0.0025
328 IRRITABILITY 148 0.0025
329 DRUG LEVEL DECREASED 25 0.0025
330 TENDON DISORDER 16 0.0025
331 ACUTE RESPIRATORY FAILURE 47 0.0024
332 ANGINA PECTORIS 70 0.0024
333 BODY TEMPERATURE DECREASED 24 0.0024
334 PARANOIA 42 0.0024
335 MENTAL IMPAIRMENT 59 0.0024
336 HAEMORRHAGIC STROKE 19 0.0024
337 HYPERCALCAEMIA 30 0.0024
338 CARPAL TUNNEL SYNDROME 34 0.0024
339 FEELING DRUNK 18 0.0024
340 SINUS TACHYCARDIA 34 0.0024
341 RENAL CYST 19 0.0024
342 GROIN PAIN 21 0.0024
343 NEURALGIA 58 0.0024
344 SINUS DISORDER 47 0.0024
345 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 80 0.0024
346 LIMB INJURY 64 0.0024
347 SPINAL OPERATION 29 0.0024
348 UNEVALUABLE EVENT 178 0.0024
349 FOOT DEFORMITY 26 0.0023
350 JOINT INJURY 50 0.0023
351 SQUAMOUS CELL CARCINOMA 22 0.0023
352 NEPHROLITHIASIS 107 0.0023
353 GYNAECOMASTIA 72 0.0023
354 TEMPERATURE INTOLERANCE 24 0.0023
355 CELLULITIS 117 0.0023
356 DEPRESSION 527 0.0023
357 MANIA 38 0.0023
358 RESTLESS LEGS SYNDROME 42 0.0023
359 PRODUCT USE COMPLAINT 36 0.0023
360 RIB FRACTURE 47 0.0023
361 CHOLECYSTECTOMY 26 0.0023
362 HEAD INJURY 72 0.0023
363 MOOD ALTERED 62 0.0023
364 MENTAL STATUS CHANGES 63 0.0023
365 TOOTH FRACTURE 25 0.0023
366 MUSCULOSKELETAL CHEST PAIN 35 0.0023
367 TENDONITIS 35 0.0023
368 AMNESIA 147 0.0023
369 HEPATIC STEATOSIS 42 0.0023
370 SCAR 38 0.0022
371 DRUG-INDUCED LIVER INJURY 69 0.0022
372 HYPERHIDROSIS 283 0.0022
373 CARDIAC MURMUR 19 0.0022
374 DEVICE DELIVERY SYSTEM ISSUE 60 0.0022
375 PERIPHERAL COLDNESS 30 0.0022
376 SUICIDAL IDEATION 199 0.0022
377 MULTIPLE ALLERGIES 17 0.0022
378 ELECTROCARDIOGRAM ABNORMAL 17 0.0022
379 CHOLELITHIASIS 71 0.0022
380 LEUKOCYTOSIS 39 0.0022
381 FEELING JITTERY 41 0.0021
382 BODY HEIGHT DECREASED 23 0.0021
383 THINKING ABNORMAL 40 0.0021
384 PRODUCT QUALITY ISSUE 291 0.0021
385 DEFAECATION URGENCY 15 0.0021
386 RHABDOMYOLYSIS 89 0.0021
387 TINNITUS 98 0.0021
388 ANKLE FRACTURE 33 0.0021
389 MICTURITION URGENCY 24 0.0021
390 BLOOD GLUCOSE FLUCTUATION 23 0.0021
391 AGGRESSION 105 0.0021
392 HOT FLUSH 158 0.0021
393 CARDIAC ARREST 173 0.0021
394 INSOMNIA 558 0.0021
395 HYPERSOMNIA 60 0.0021
396 JOINT RANGE OF MOTION DECREASED 28 0.0021
397 CHROMATURIA 47 0.0021
398 ROAD TRAFFIC ACCIDENT 87 0.0021
399 PAIN 1276 0.0021
400 SLEEP DISORDER 146 0.0021
401 FOOT FRACTURE 39 0.0021
402 CHEST PAIN 381 0.0021
403 APATHY 30 0.0021
404 PROTEINURIA 39 0.0020
405 BLOOD PRESSURE SYSTOLIC INCREASED 40 0.0020
406 GASTROOESOPHAGEAL REFLUX DISEASE 165 0.0020
407 INITIAL INSOMNIA 21 0.0020
408 NECK PAIN 114 0.0020
409 LIGAMENT SPRAIN 20 0.0020
410 BLOOD PRESSURE INCREASED 309 0.0020
411 PULMONARY THROMBOSIS 22 0.0020
412 CHOLECYSTITIS 24 0.0020
413 HYPERTENSION 426 0.0020
414 WEIGHT FLUCTUATION 21 0.0020
415 MYOSITIS 18 0.0020
416 ABSCESS 32 0.0020
417 HYDRONEPHROSIS 15 0.0020
418 PHOTOSENSITIVITY REACTION 33 0.0020
419 LETHARGY 114 0.0020
420 BURSITIS 24 0.0020
421 TOOTH INFECTION 26 0.0020
422 BACK DISORDER 32 0.0020
423 PRODUCT STORAGE ERROR 171 0.0020
424 MUSCLE TWITCHING 45 0.0020
425 SMALL INTESTINAL OBSTRUCTION 24 0.0019
426 NO ADVERSE EVENT 353 0.0019
427 FLUSHING 198 0.0019
428 STAPHYLOCOCCAL INFECTION 64 0.0019
429 ACUTE KIDNEY INJURY 296 0.0019
430 DEVICE INFORMATION OUTPUT ISSUE 15 0.0019
431 VENTRICULAR EXTRASYSTOLES 20 0.0019
432 PULMONARY HYPERTENSION 40 0.0019
433 THERAPEUTIC PRODUCT EFFECT DECREASED 86 0.0019
434 NODULE 25 0.0019
435 PAIN IN JAW 54 0.0019
436 DENTAL CARIES 21 0.0019
437 HIP ARTHROPLASTY 29 0.0019
438 INJECTION SITE MASS 70 0.0019
439 VENTRICULAR TACHYCARDIA 31 0.0019
440 PANCREATITIS 99 0.0019
441 TUBULOINTERSTITIAL NEPHRITIS 35 0.0019
442 ASTHENIA 702 0.0019
443 HYPERCHOLESTEROLAEMIA 18 0.0019
444 COORDINATION ABNORMAL 26 0.0019
445 DRUG ADMINISTRATION ERROR 57 0.0019
446 NEEDLE ISSUE 54 0.0019
447 DEPRESSED MOOD 98 0.0019
448 LACRIMATION INCREASED 56 0.0019
449 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 89 0.0019
450 PNEUMONIA BACTERIAL 17 0.0019
451 IMPAIRED DRIVING ABILITY 21 0.0018
452 DEVICE DEFECTIVE 32 0.0018
453 BLOOD CHOLESTEROL INCREASED 86 0.0018
454 NERVE COMPRESSION 17 0.0018
455 CARDIAC DISORDER 172 0.0018
456 INCORRECT DOSE ADMINISTERED BY DEVICE 48 0.0018
457 ACUTE HEPATIC FAILURE 25 0.0018
458 INCORRECT PRODUCT STORAGE 24 0.0018
459 BEDRIDDEN 24 0.0018
460 SKIN HAEMORRHAGE 27 0.0018
461 OEDEMA PERIPHERAL 222 0.0018
462 LOCALISED INFECTION 44 0.0018
463 DRUG EFFECT DECREASED 98 0.0018
464 THYROID DISORDER 28 0.0018
465 LUNG INFILTRATION 16 0.0018
466 HYPONATRAEMIA 102 0.0018
467 SURGERY 106 0.0018
468 FEELING ABNORMAL 432 0.0018
469 HYPERTHYROIDISM 26 0.0018
470 BACK PAIN 417 0.0018
471 CARDIOTOXICITY 16 0.0018
472 BALANCE DISORDER 155 0.0018
473 PRODUCT DISPENSING ERROR 39 0.0018
474 COGNITIVE DISORDER 83 0.0018
475 SINUSITIS 182 0.0018
476 ABNORMAL DREAMS 49 0.0018
477 IRRITABLE BOWEL SYNDROME 38 0.0018
478 EYE INFECTION 20 0.0018
479 POST PROCEDURAL COMPLICATION 34 0.0018
480 DISABILITY 35 0.0018
481 TOOTH ABSCESS 18 0.0018
482 HEART RATE DECREASED 62 0.0018
483 SLUGGISHNESS 18 0.0018
484 PSYCHOTIC DISORDER 52 0.0018
485 ERUCTATION 34 0.0018
486 EUPHORIC MOOD 18 0.0018
487 HIDRADENITIS 16 0.0018
488 DIZZINESS POSTURAL 17 0.0018
489 WRIST FRACTURE 21 0.0018
490 HEAD DISCOMFORT 31 0.0017
491 SKIN LESION 48 0.0017
492 RED BLOOD CELL COUNT DECREASED 50 0.0017
493 ORAL CANDIDIASIS 23 0.0017
494 ABNORMAL BEHAVIOUR 69 0.0017
495 DISORIENTATION 69 0.0017
496 RETINAL DETACHMENT 16 0.0017
497 RENAL IMPAIRMENT 146 0.0017
498 IRON DEFICIENCY ANAEMIA 16 0.0017
499 AGITATION 127 0.0017
500 AGEUSIA 43 0.0017
501 MENTAL DISORDER 75 0.0017
502 ORTHOSTATIC HYPOTENSION 30 0.0017
503 HYPOTHYROIDISM 55 0.0017
504 RENAL FAILURE 228 0.0017
505 TOOTHACHE 31 0.0017
506 DYSURIA 63 0.0017
507 BLOOD CREATININE INCREASED 111 0.0017
508 PALLOR 46 0.0017
509 SPUTUM DISCOLOURED 16 0.0017
510 WEIGHT DECREASED 470 0.0017
511 BLOOD GLUCOSE ABNORMAL 31 0.0017
512 SUBARACHNOID HAEMORRHAGE 17 0.0017
513 PULMONARY CONGESTION 22 0.0017
514 INTENTIONAL PRODUCT USE ISSUE 146 0.0017
515 UPPER RESPIRATORY TRACT INFECTION 77 0.0017
516 FATIGUE 1297 0.0017
517 MYALGIA 283 0.0017
518 STEVENS-JOHNSON SYNDROME 37 0.0017
519 PARAESTHESIA ORAL 24 0.0017
520 HYPOMAGNESAEMIA 23 0.0017
521 COLD SWEAT 29 0.0016
522 INTRAOCULAR PRESSURE INCREASED 21 0.0016
523 HAEMORRHOIDS 32 0.0016
524 NEUROPATHY PERIPHERAL 156 0.0016
525 DIABETES MELLITUS 125 0.0016
526 ARTHROPATHY 91 0.0016
527 GASTROINTESTINAL PAIN 18 0.0016
528 INJECTION SITE NODULE 18 0.0016
529 CONTUSION 156 0.0016
530 TACHYPNOEA 22 0.0016
531 ACTIVITIES OF DAILY LIVING IMPAIRED 32 0.0016
532 HEART RATE INCREASED 160 0.0016
533 MALNUTRITION 18 0.0016
534 UPPER LIMB FRACTURE 32 0.0016
535 TYPE 2 DIABETES MELLITUS 54 0.0016
536 CLOSTRIDIUM DIFFICILE COLITIS 17 0.0016
537 BLOOD IRON DECREASED 19 0.0016
538 IMPAIRED QUALITY OF LIFE 23 0.0016
539 WEIGHT INCREASED 358 0.0016
540 BONE LOSS 24 0.0016
541 WITHDRAWAL SYNDROME 67 0.0016
542 PRODUCT PRESCRIBING ERROR 38 0.0016
543 IMMUNE SYSTEM DISORDER 21 0.0016
544 GLYCOSYLATED HAEMOGLOBIN INCREASED 40 0.0016
545 RESTLESSNESS 58 0.0016
546 ARRHYTHMIA 75 0.0016
547 BRAIN OEDEMA 20 0.0016
548 MULTIPLE FRACTURES 26 0.0016
549 BRONCHITIS 117 0.0016
550 MUSCLE SPASMS 289 0.0016
551 TREATMENT NONCOMPLIANCE 86 0.0016
552 INSURANCE ISSUE 24 0.0016
553 DYSARTHRIA 59 0.0016
554 NASAL CONGESTION 92 0.0016
555 JOINT STIFFNESS 41 0.0016
556 PRESYNCOPE 38 0.0016
557 EAR DISCOMFORT 16 0.0016
558 LABORATORY TEST ABNORMAL 46 0.0016
559 BLOOD UREA INCREASED 26 0.0016
560 OFF LABEL USE 1357 0.0015
561 POST PROCEDURAL HAEMORRHAGE 18 0.0015
562 DELUSION 24 0.0015
563 HIATUS HERNIA 20 0.0015
564 HYPERBILIRUBINAEMIA 16 0.0015
565 INTENTIONAL DOSE OMISSION 44 0.0015
566 INTERNATIONAL NORMALISED RATIO INCREASED 44 0.0015
567 DIPLOPIA 40 0.0015
568 ABNORMAL WEIGHT GAIN 19 0.0015
569 TENDERNESS 16 0.0015
570 DEVICE MECHANICAL ISSUE 21 0.0015
571 BLOOD URINE PRESENT 29 0.0015
572 HAIR COLOUR CHANGES 19 0.0015
573 IMPAIRED HEALING 50 0.0015
574 INCREASED APPETITE 29 0.0015
575 BLOOD CALCIUM DECREASED 17 0.0015
576 BURNING SENSATION 106 0.0015
577 ARTHRALGIA 625 0.0015
578 WOUND 42 0.0015
579 HERNIA 29 0.0015
580 SENSORY DISTURBANCE 24 0.0015
581 TOOTH LOSS 31 0.0015
582 DEVICE MALFUNCTION 105 0.0015
583 DRUG INTERACTION 237 0.0015
584 SYNCOPE 149 0.0015
585 BLINDNESS UNILATERAL 21 0.0015
586 MUSCULOSKELETAL PAIN 78 0.0015
587 SKIN FISSURES 29 0.0015
588 FIBROMYALGIA 36 0.0015
589 DIVERTICULITIS 41 0.0015
590 DERMATITIS 31 0.0015
591 PARAESTHESIA 232 0.0015
592 PULMONARY OEDEMA 66 0.0015
593 THROAT IRRITATION 66 0.0015
594 LYMPHADENOPATHY 52 0.0015
595 HAEMATOMA 38 0.0015
596 PRODUCTIVE COUGH 70 0.0015
597 LOWER LIMB FRACTURE 28 0.0015
598 RHINORRHOEA 94 0.0015
599 EYE PAIN 82 0.0015
600 DYSPHONIA 85 0.0015
601 PRODUCT DOSE OMISSION ISSUE 427 0.0015
602 TACHYCARDIA 129 0.0015
603 TOOTH EXTRACTION 18 0.0014
604 CHEST DISCOMFORT 148 0.0014
605 MEMORY IMPAIRMENT 197 0.0014
606 PROSTATE CANCER 115 0.0014
607 PERIPHERAL SWELLING 220 0.0014
608 HYPERKALAEMIA 50 0.0014
609 MIGRAINE 136 0.0014
610 BLOOD CREATINE PHOSPHOKINASE INCREASED 41 0.0014
611 BLOOD TEST ABNORMAL 20 0.0014
612 PRODUCT PRESCRIBING ISSUE 31 0.0014
613 SWELLING 133 0.0014
614 NIGHTMARE 49 0.0014
615 EJECTION FRACTION DECREASED 22 0.0014
616 ACNE 107 0.0014
617 HYPOAESTHESIA 211 0.0014
618 EATING DISORDER 30 0.0014
619 URINARY RETENTION 47 0.0014
620 CARDIAC FAILURE 113 0.0014
621 BREAST PAIN 15 0.0014
622 PSORIATIC ARTHROPATHY 57 0.0014
623 TREMOR 233 0.0014
624 SCAB 16 0.0014
625 RASH PRURITIC 76 0.0014
626 HEADACHE 879 0.0014
627 SOMNOLENCE 282 0.0014
628 SPINAL FRACTURE 28 0.0014
629 MUSCULOSKELETAL DISCOMFORT 24 0.0014
630 NO THERAPEUTIC RESPONSE 17 0.0014
631 ABDOMINAL PAIN 324 0.0014
632 DYSPEPSIA 137 0.0014
633 GENERALISED TONIC-CLONIC SEIZURE 23 0.0014
634 PRODUCT USE ISSUE 260 0.0014
635 PHOTOPHOBIA 26 0.0014
636 COAGULOPATHY 23 0.0014
637 EPILEPSY 42 0.0014
638 HALLUCINATION, VISUAL 29 0.0014
639 HAEMATURIA 47 0.0014
640 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 278 0.0014
641 ACCIDENTAL EXPOSURE TO PRODUCT 141 0.0014
642 DRY MOUTH 111 0.0014
643 THROAT TIGHTNESS 37 0.0014
644 ANKYLOSING SPONDYLITIS 18 0.0014
645 DEVICE RELATED INFECTION 21 0.0014
646 INJECTION SITE DISCOLOURATION 17 0.0014
647 DISCOMFORT 83 0.0014
648 MASS 19 0.0014
649 SKIN ULCER 35 0.0014
650 SEROTONIN SYNDROME 26 0.0014
651 EAR INFECTION 36 0.0014
652 THERAPEUTIC RESPONSE DECREASED 82 0.0014
653 PALPITATIONS 158 0.0013
654 BONE PAIN 79 0.0013
655 CONSTIPATION 294 0.0013
656 PAIN IN EXTREMITY 397 0.0013
657 NERVOUS SYSTEM DISORDER 42 0.0013
658 GAIT DISTURBANCE 257 0.0013
659 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 23 0.0013
660 LIVER FUNCTION TEST ABNORMAL 39 0.0013
661 FLATULENCE 76 0.0013
662 FLUID RETENTION 68 0.0013
663 INFLUENZA 149 0.0013
664 FISTULA 15 0.0013
665 JOINT SWELLING 161 0.0013
666 BLOOD PRESSURE FLUCTUATION 32 0.0013
667 SINUS CONGESTION 18 0.0013
668 GASTRITIS 35 0.0013
669 PARALYSIS 19 0.0013
670 PSYCHOMOTOR HYPERACTIVITY 22 0.0013
671 BODY TEMPERATURE INCREASED 27 0.0013
672 RESPIRATORY TRACT CONGESTION 21 0.0013
673 HALLUCINATION, AUDITORY 21 0.0013
674 PELVIC PAIN 24 0.0013
675 SKIN DISORDER 44 0.0013
676 INJECTION SITE SWELLING 101 0.0013
677 MUSCULOSKELETAL DISORDER 25 0.0013
678 ARTHRITIS 103 0.0013
679 FEELING HOT 80 0.0013
680 ENCEPHALOPATHY 32 0.0013
681 ABDOMINAL DISTENSION 136 0.0013
682 RESPIRATORY FAILURE 95 0.0013
683 MUSCULAR WEAKNESS 148 0.0013
684 DIZZINESS 649 0.0013
685 DIABETES MELLITUS INADEQUATE CONTROL 23 0.0013
686 HEMIPARESIS 22 0.0013
687 MUSCLE TIGHTNESS 21 0.0013
688 PANCREATITIS ACUTE 29 0.0013
689 DEHYDRATION 172 0.0013
690 DEVICE BREAKAGE 52 0.0013
691 SWOLLEN TONGUE 40 0.0013
692 RENAL INJURY 38 0.0013
693 GASTROENTERITIS VIRAL 23 0.0013
694 BLOOD SODIUM DECREASED 24 0.0013
695 OSTEOMYELITIS 23 0.0013
696 FALL 422 0.0013
697 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 90 0.0013
698 NERVOUSNESS 66 0.0013
699 PROCEDURAL PAIN 35 0.0013
700 HAEMATOCRIT DECREASED 25 0.0013
701 LIMB DISCOMFORT 39 0.0013
702 CONDITION AGGRAVATED 383 0.0013
703 BLOOD PRESSURE ABNORMAL 25 0.0013
704 SCIATICA 20 0.0013
705 INFLUENZA LIKE ILLNESS 103 0.0013
706 ORAL PAIN 28 0.0012
707 DRUG INEFFECTIVE 1646 0.0012
708 HEPATIC ENZYME INCREASED 85 0.0012
709 PRODUCT USE IN UNAPPROVED INDICATION 309 0.0012
710 AKATHISIA 17 0.0012
711 HYPOKINESIA 18 0.0012
712 INCORRECT DOSE ADMINISTERED 283 0.0012
713 DYSGEUSIA 92 0.0012
714 EXPOSURE VIA SKIN CONTACT 32 0.0012
715 INJECTION SITE INDURATION 16 0.0012
716 LOSS OF CONSCIOUSNESS 158 0.0012
717 UNDERDOSE 90 0.0012
718 GALLBLADDER DISORDER 22 0.0012
719 THIRST 22 0.0012
720 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 64 0.0012
721 APHASIA 37 0.0012
722 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 87 0.0012
723 DYSPNOEA EXERTIONAL 46 0.0012
724 FEELING COLD 34 0.0012
725 HYPOXIA 43 0.0012
726 HUNGER 17 0.0012
727 DEVICE DISLOCATION 53 0.0012
728 HAEMOPTYSIS 34 0.0012
729 URINARY INCONTINENCE 36 0.0012
730 HYPOKALAEMIA 56 0.0012
731 GASTRIC ULCER 23 0.0012
732 ILEUS 15 0.0012
733 DEVICE LEAKAGE 52 0.0012
734 WHITE BLOOD CELL COUNT INCREASED 46 0.0012
735 BLOOD POTASSIUM DECREASED 36 0.0012
736 CLOSTRIDIUM DIFFICILE INFECTION 26 0.0012
737 UPPER GASTROINTESTINAL HAEMORRHAGE 20 0.0012
738 KNEE ARTHROPLASTY 25 0.0012
739 ACUTE RESPIRATORY DISTRESS SYNDROME 21 0.0012
740 FREQUENT BOWEL MOVEMENTS 32 0.0012
741 NAUSEA 937 0.0012
742 EYE SWELLING 44 0.0012
743 HYPERGLYCAEMIA 43 0.0012
744 INJECTION SITE PAIN 360 0.0012
745 PNEUMONIA 379 0.0012
746 PRODUCT DOSE OMISSION IN ERROR 33 0.0012
747 GASTROENTERITIS 17 0.0012
748 EPISTAXIS 87 0.0012
749 BLISTER 65 0.0012
750 CONFUSIONAL STATE 187 0.0012
751 METABOLIC ACIDOSIS 37 0.0012
752 HYPOGLYCAEMIA 56 0.0012
753 MUSCULOSKELETAL STIFFNESS 101 0.0012
754 JAUNDICE 31 0.0012
755 VISION BLURRED 158 0.0011
756 DRUG LEVEL INCREASED 19 0.0011
757 DRY EYE 57 0.0011
758 PRODUCT AVAILABILITY ISSUE 26 0.0011
759 AMENORRHOEA 20 0.0011
760 OSTEONECROSIS OF JAW 28 0.0011
761 ULCER 18 0.0011
762 PERICARDITIS 19 0.0011
763 CRYING 41 0.0011
764 INJECTION SITE HAEMORRHAGE 90 0.0011
765 CHILLS 132 0.0011
766 RETCHING 24 0.0011
767 OEDEMA 61 0.0011
768 UNRESPONSIVE TO STIMULI 29 0.0011
769 HAEMATOCHEZIA 62 0.0011
770 HAIR TEXTURE ABNORMAL 15 0.0011
771 BLOOD COUNT ABNORMAL 17 0.0011
772 DYSPNOEA 633 0.0011
773 CEREBRAL HAEMORRHAGE 40 0.0011
774 DEVICE FAILURE 17 0.0011
775 ILLNESS 115 0.0011
776 RASH MACULAR 39 0.0011
777 SKIN CANCER 24 0.0011
778 EXPIRED PRODUCT ADMINISTERED 37 0.0011
779 COUGH 312 0.0011
780 DRUG DISPENSING ERROR 17 0.0011
781 EYE IRRITATION 64 0.0011
782 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 61 0.0011
783 RESPIRATORY DISORDER 33 0.0011
784 OCULAR HYPERAEMIA 52 0.0011
785 CHOLESTASIS 21 0.0011
786 NEOPLASM PROGRESSION 38 0.0011
787 ALANINE AMINOTRANSFERASE INCREASED 67 0.0011
788 THERAPY CESSATION 56 0.0011
789 DEVICE USE ISSUE 19 0.0011
790 INFLAMMATION 56 0.0011
791 VISUAL IMPAIRMENT 134 0.0011
792 HERPES ZOSTER 62 0.0011
793 COVID-19 189 0.0011
794 DECREASED APPETITE 250 0.0011
795 RESPIRATORY TRACT INFECTION 28 0.0011
796 LIVER FUNCTION TEST INCREASED 23 0.0011
797 PRODUCT PREPARATION ERROR 22 0.0011
798 DEAFNESS 28 0.0011
799 SNEEZING 24 0.0011
800 DISSEMINATED INTRAVASCULAR COAGULATION 15 0.0011
801 BLOOD GLUCOSE DECREASED 51 0.0011
802 DYSSTASIA 31 0.0011
803 HALLUCINATION 80 0.0011
804 ABDOMINAL DISCOMFORT 178 0.0011
805 SWELLING FACE 69 0.0011
806 DEVICE ISSUE 95 0.0011
807 MOBILITY DECREASED 76 0.0011
808 DYSPHAGIA 100 0.0011
809 PLEURAL EFFUSION 64 0.0011
810 VERTIGO 64 0.0010
811 SEPSIS 117 0.0010
812 SEIZURE 121 0.0010
813 PRODUCT DOSE OMISSION 68 0.0010
814 DRUG PRESCRIBING ERROR 20 0.0010
815 PNEUMONIA ASPIRATION 26 0.0010
816 LUNG DISORDER 51 0.0010
817 HYPERSENSITIVITY 193 0.0010
818 DRUG WITHDRAWAL SYNDROME 91 0.0010
819 RENAL FAILURE ACUTE 44 0.0010
820 ANOSMIA 15 0.0010
821 SEDATION 27 0.0010
822 EAR PAIN 20 0.0010
823 WHEEZING 61 0.0010
824 MALAISE 451 0.0010
825 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 185 0.0010
826 RASH PAPULAR 23 0.0010
827 CATARACT 61 0.0010
828 INFECTION 148 0.0010
829 BACTERIAL INFECTION 19 0.0010
830 FAECES DISCOLOURED 22 0.0010
831 DIARRHOEA 653 0.0010
832 DISEASE RECURRENCE 48 0.0010
833 RENAL DISORDER 47 0.0010
834 CYSTITIS 32 0.0010
835 RASH GENERALISED 26 0.0010
836 ANAEMIA 191 0.0010
837 DRUG DOSE OMISSION 165 0.0010
838 HYPOAESTHESIA ORAL 15 0.0010
839 THERAPEUTIC RESPONSE SHORTENED 33 0.0010
840 PRURITUS 382 0.0010
841 SPEECH DISORDER 52 0.0010
842 VIRAL INFECTION 33 0.0010
843 TRANSAMINASES INCREASED 22 0.0010
844 TOOTH DISORDER 22 0.0010
845 ABDOMINAL PAIN LOWER 25 0.0010
846 HEPATOTOXICITY 22 0.0010
847 HYPOPHAGIA 25 0.0010
848 ABDOMINAL PAIN UPPER 201 0.0010
849 METASTASES TO BONE 16 0.0010
850 HYPOTENSION 195 0.0010
851 KIDNEY INFECTION 19 0.0010
852 BLOOD GLUCOSE INCREASED 182 0.0010
853 RASH 420 0.0010
854 VISUAL ACUITY REDUCED 32 0.0010
855 BLOOD BILIRUBIN INCREASED 26 0.0010
856 BRADYCARDIA 51 0.0010
857 SKIN IRRITATION 44 0.0010
858 FUNGAL INFECTION 32 0.0010
859 GASTROINTESTINAL DISORDER 86 0.0010
860 DRUG DOSE OMISSION BY DEVICE 75 0.0010
861 SKIN DISCOLOURATION 44 0.0010
862 MEDICATION ERROR 53 0.0010
863 DRUG INTOLERANCE 92 0.0010
864 EYE PRURITUS 32 0.0010
865 BLOOD PRESSURE DECREASED 63 0.0009
866 INJECTION SITE BRUISING 75 0.0009
867 COLITIS ULCERATIVE 42 0.0009
868 PULMONARY FIBROSIS 18 0.0009
869 TASTE DISORDER 19 0.0009
870 HAEMOGLOBIN DECREASED 96 0.0009
871 CARDIO-RESPIRATORY ARREST 39 0.0009
872 HEPATIC FAILURE 28 0.0009
873 BLOOD ALKALINE PHOSPHATASE INCREASED 23 0.0009
874 PHARMACEUTICAL PRODUCT COMPLAINT 24 0.0009
875 ALOPECIA 181 0.0009
876 ASCITES 27 0.0009
877 CONJUNCTIVITIS 17 0.0009
878 PYREXIA 316 0.0009
879 ASTHMA 103 0.0009
880 DERMATITIS ATOPIC 48 0.0009
881 DRUG EFFECT INCOMPLETE 33 0.0009
882 BLINDNESS 37 0.0009
883 FEMUR FRACTURE 28 0.0009
884 ASPARTATE AMINOTRANSFERASE INCREASED 48 0.0009
885 HEPATITIS 23 0.0009
886 VAGINAL HAEMORRHAGE 39 0.0009
887 PSORIASIS 117 0.0009
888 ADVERSE DRUG REACTION 80 0.0009
889 CANDIDA INFECTION 15 0.0009
890 FEEDING DISORDER 18 0.0009
891 OROPHARYNGEAL PAIN 82 0.0009
892 ERYTHEMA 182 0.0009
893 VOMITING 415 0.0009
894 ECZEMA 46 0.0009
895 RASH ERYTHEMATOUS 42 0.0009
896 INCORRECT PRODUCT ADMINISTRATION DURATION 19 0.0009
897 INTESTINAL OBSTRUCTION 33 0.0009
898 MOVEMENT DISORDER 28 0.0009
899 URTICARIA 146 0.0009
900 PERICARDIAL EFFUSION 20 0.0009
901 GASTROINTESTINAL HAEMORRHAGE 72 0.0009
902 INTENTIONAL DRUG MISUSE 18 0.0009
903 INJECTION SITE URTICARIA 21 0.0009
904 WRONG TECHNIQUE IN DRUG USAGE PROCESS 31 0.0009
905 NASOPHARYNGITIS 157 0.0009
906 FRACTURE 16 0.0008
907 ILL-DEFINED DISORDER 51 0.0008
908 OXYGEN SATURATION DECREASED 47 0.0008
909 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 39 0.0008
910 GLAUCOMA 16 0.0008
911 HAEMATEMESIS 21 0.0008
912 THERAPY INTERRUPTED 59 0.0008
913 SUICIDE ATTEMPT 50 0.0008
914 THERAPY NON-RESPONDER 37 0.0008
915 ORAL HERPES 16 0.0008
916 ANGIOEDEMA 36 0.0008
917 GENERAL PHYSICAL HEALTH DETERIORATION 94 0.0008
918 DYSKINESIA 33 0.0008
919 ABASIA 20 0.0008
920 URINARY TRACT INFECTION 138 0.0008
921 HIP FRACTURE 26 0.0008
922 MOUTH ULCERATION 17 0.0008
923 SKIN EXFOLIATION 68 0.0008
924 GLOSSODYNIA 18 0.0008
925 RESPIRATORY DISTRESS 22 0.0008
926 DRY SKIN 106 0.0008
927 INTENTIONAL SELF-INJURY 16 0.0008
928 PNEUMONITIS 21 0.0008
929 CONTRAINDICATED PRODUCT ADMINISTERED 23 0.0008
930 GASTRIC DISORDER 26 0.0008
931 INJECTION SITE PRURITUS 50 0.0007
932 DRUG RESISTANCE 19 0.0007
933 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 19 0.0007
934 BONE MARROW FAILURE 15 0.0007
935 HAEMORRHAGE 76 0.0007
936 THROMBOCYTOPENIA 81 0.0007
937 HEPATIC FUNCTION ABNORMAL 27 0.0007
938 RECTAL HAEMORRHAGE 31 0.0007
939 DELIRIUM 25 0.0007
940 GAIT INABILITY 24 0.0007
941 INJECTION SITE REACTION 49 0.0007
942 ACCIDENTAL OVERDOSE 26 0.0007
943 WHITE BLOOD CELL COUNT DECREASED 77 0.0007
944 BREAST CANCER 66 0.0007
945 DEPRESSED LEVEL OF CONSCIOUSNESS 28 0.0007
946 ANAPHYLACTIC REACTION 39 0.0007
947 ADVERSE EVENT 65 0.0007
948 CONVULSION 40 0.0007
949 EXTRA DOSE ADMINISTERED 28 0.0007
950 COLITIS 26 0.0007
951 INJECTION SITE ERYTHEMA 85 0.0007
952 DEMENTIA 19 0.0007
953 INFUSION RELATED REACTION 45 0.0007
954 MULTIPLE ORGAN DYSFUNCTION SYNDROME 19 0.0007
955 PLATELET COUNT DECREASED 70 0.0007
956 HYPOACUSIS 28 0.0006
957 EYE DISORDER 21 0.0006
958 PAIN OF SKIN 17 0.0006
959 COMA 30 0.0006
960 STOMATITIS 38 0.0006
961 LUNG NEOPLASM MALIGNANT 25 0.0006
962 MULTIPLE SCLEROSIS 29 0.0006
963 DEVICE USE ERROR 21 0.0006
964 LIP SWELLING 20 0.0006
965 SEPTIC SHOCK 26 0.0006
966 INTENTIONAL OVERDOSE 38 0.0006
967 INJECTION SITE RASH 18 0.0006
968 ELECTROCARDIOGRAM QT PROLONGED 20 0.0006
969 OVERDOSE 117 0.0005
970 PLASMA CELL MYELOMA 21 0.0005
971 COMPLETED SUICIDE 44 0.0005
972 HOSPITALISATION 80 0.0005
973 NEOPLASM MALIGNANT 34 0.0005
974 DEATH 434 0.0005
975 DISEASE PROGRESSION 59 0.0005
976 NEUTROPHIL COUNT DECREASED 20 0.0005
977 SKIN BURNING SENSATION 33 0.0005
978 TREATMENT FAILURE 38 0.0005
979 MULTIPLE SCLEROSIS RELAPSE 31 0.0005
980 TOXICITY TO VARIOUS AGENTS 75 0.0004
981 RHEUMATOID ARTHRITIS 50 0.0004
982 LOWER RESPIRATORY TRACT INFECTION 20 0.0004
983 PANCYTOPENIA 24 0.0004
984 C-REACTIVE PROTEIN INCREASED 15 0.0004
985 DEVICE EXPULSION 26 0.0004
986 MALIGNANT NEOPLASM PROGRESSION 41 0.0004
987 LIVER DISORDER 17 0.0004
988 LEUKOPENIA 18 0.0004
989 FEBRILE NEUTROPENIA 23 0.0003
990 DRUG DEPENDENCE 54 0.0003
991 BLADDER CANCER 19 0.0003
992 DEVICE DIFFICULT TO USE 18 0.0003
993 NEUTROPENIA 34 0.0002